CY1105925T1 - Διepγασια για ανακτηση ενωσεων στατινης απο ενα ζωμο ζυμωσης - Google Patents

Διepγασια για ανακτηση ενωσεων στατινης απο ενα ζωμο ζυμωσης

Info

Publication number
CY1105925T1
CY1105925T1 CY20071100052T CY071100052T CY1105925T1 CY 1105925 T1 CY1105925 T1 CY 1105925T1 CY 20071100052 T CY20071100052 T CY 20071100052T CY 071100052 T CY071100052 T CY 071100052T CY 1105925 T1 CY1105925 T1 CY 1105925T1
Authority
CY
Cyprus
Prior art keywords
fermentation
compound
breed
recovery
statin compounds
Prior art date
Application number
CY20071100052T
Other languages
Greek (el)
English (en)
Inventor
Vilmos Keri
Lajos Deak
Ilona Forgacs
Csaba Szabo
Edit Arvai Nagyne
Original Assignee
Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22609918&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1105925(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag filed Critical Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag
Publication of CY1105925T1 publication Critical patent/CY1105925T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/62—Carboxylic acid esters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C07C67/52—Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/013—Esters of alcohols having the esterified hydroxy group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
    • C07C69/33—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with hydroxy compounds having more than three hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/42—Hydroxy-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/26—All rings being cycloaliphatic the ring system containing ten carbon atoms
    • C07C2602/28—Hydrogenated naphthalenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nanotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Manufacturing & Machinery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CY20071100052T 1999-11-30 2007-01-15 Διepγασια για ανακτηση ενωσεων στατινης απο ενα ζωμο ζυμωσης CY1105925T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16805699P 1999-11-30 1999-11-30
PCT/US2000/032391 WO2001039768A1 (en) 1999-11-30 2000-11-28 Process for recovering statin compounds from a fermentation broth

Publications (1)

Publication Number Publication Date
CY1105925T1 true CY1105925T1 (el) 2011-04-06

Family

ID=22609918

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071100052T CY1105925T1 (el) 1999-11-30 2007-01-15 Διepγασια για ανακτηση ενωσεων στατινης απο ενα ζωμο ζυμωσης

Country Status (22)

Country Link
US (3) US6444452B1 (enExample)
EP (1) EP1265604B1 (enExample)
JP (5) JP3881240B2 (enExample)
KR (1) KR20030026920A (enExample)
CN (2) CN1754872A (enExample)
AT (2) ATE382344T1 (enExample)
AU (1) AU1804601A (enExample)
CA (1) CA2393057C (enExample)
CY (1) CY1105925T1 (enExample)
DE (3) DE60031447T2 (enExample)
DK (1) DK1265604T3 (enExample)
ES (2) ES2273737T3 (enExample)
HR (1) HRP20020454A2 (enExample)
HU (1) HUP0204012A3 (enExample)
MX (1) MXPA02005283A (enExample)
PL (1) PL364918A1 (enExample)
PT (1) PT1265604E (enExample)
RU (1) RU2002114072A (enExample)
SK (1) SK7342002A3 (enExample)
WO (1) WO2001039768A1 (enExample)
YU (1) YU39102A (enExample)
ZA (1) ZA200203912B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141602B2 (en) * 1998-09-18 2006-11-28 Lek Pharmaceuticals D.D. Process for obtaining HMG-CoA reductase inhibitors of high purity
US6682913B1 (en) * 1999-02-03 2004-01-27 Institute For Drug Research Ltd. Microbial process for preparing pravastatin
ES2273737T3 (es) * 1999-11-30 2007-05-16 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Procedimiento para la recuperacion de compuestos de estatina de un caldo de fermentacion.
IL150187A0 (en) * 1999-12-14 2002-12-01 Biogal Pharmaceutical Co Ltd Novel forms of pravastatin sodium
HRP20030347A2 (en) * 2000-10-05 2005-04-30 Teva Gy�gyszergy�r R�szv�nyt�rsas�g Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and compositions containing same
US20050215636A1 (en) * 2000-10-05 2005-09-29 Vilmos Keri Pravastatin sodium substantially free of pravastatin lactone and EPI-pravastatin, and compositions containing same
JP2002121172A (ja) * 2000-10-16 2002-04-23 Sankyo Co Ltd プラバスタチン又はその薬理上許容される塩の精製方法
DE10119718A1 (de) * 2001-04-21 2002-10-31 Boehringer Ingelheim Pharma Verfahren zur kontinuierlichen Herstellung inhalierfähiger Arzneistoffe, Vorrichtung zur Durchführung des Verfahrens und nach diesem Verfahren hergestellter Arzneistoff
JP2003026634A (ja) * 2001-07-17 2003-01-29 Mercian Corp プラバスタチンナトリウム塩の製造方法
US6716615B2 (en) 2002-02-27 2004-04-06 Yung Shin Pharmaceutical Ind. Co., Ltd. Strains of saccharaothrix, process for producing pravastatin using the strains and isolation process of (HMG)-CoA reductase
JP3422791B2 (ja) 2002-08-06 2003-06-30 三共株式会社 プラバスタチンの単離・精製方法
KR100540761B1 (ko) * 2002-08-09 2006-01-16 코바이오텍 (주) 프라바스타틴 나트륨의 제조방법
EP1477471A1 (en) * 2003-05-14 2004-11-17 Chunghwa Chemical Synthesis & Biotech Co., Ltd. Process for purifying pravastin sodium from a fermentation broth
EP2033636A1 (en) * 2003-11-24 2009-03-11 TEVA Gyógyszergyár Zártkörüen Müködö Részvénytársaság Method of purifying pravastatin
WO2005054253A1 (en) * 2003-12-05 2005-06-16 Biocon Limited Process for the purification of macrolides
WO2006046130A2 (en) * 2004-10-29 2006-05-04 Ranbaxy Laboratories Limited Process for the preparation of pravastatin
US20060194984A1 (en) * 2005-02-09 2006-08-31 Vilmos Keri Methods of making pravastatin sodium
JP4813841B2 (ja) * 2005-07-25 2011-11-09 キユーピー株式会社 プラバスタチンナトリウムの製造方法
DE102006028817A1 (de) * 2006-06-21 2007-12-27 Evonik Degussa Gmbh Aufarbeitung von Reaktionslösungen aus Ganzzell-Biotransformationen
WO2009078033A2 (en) * 2007-12-18 2009-06-25 Themis Medicare Limited Isolation and recovery of simvastatin in lactone form or in the form of an acid salt from the harvested fermentation broth
EP2274267B1 (en) * 2008-04-02 2012-01-04 DSM IP Assets B.V. Pravastatin extraction
IN2009MU00380A (enExample) * 2009-02-18 2010-04-02
CN102993145B (zh) * 2011-09-19 2015-06-03 北大方正集团有限公司 一种提取纯化洛伐他汀的方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4319039A (en) * 1979-06-15 1982-03-09 Merck & Co., Inc. Preparation of ammonium salt of hypocholesteremic fermentation product
DK149080C (da) * 1980-06-06 1986-07-28 Sankyo Co Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre
ATE69602T1 (de) * 1985-09-13 1991-12-15 Sankyo Co Hydroxy-ml-236b-derivate, deren herstellung und anwendung.
US4857547A (en) * 1988-01-07 1989-08-15 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
US4857522A (en) * 1988-03-21 1989-08-15 E. R. Squibb & Sons, Inc. Derivatives of pravastatin for inhibiting cholesterol biosynthesis
US5180589A (en) * 1988-03-31 1993-01-19 E. R. Squibb & Sons, Inc. Pravastatin pharmaceuatical compositions having good stability
US5099035A (en) * 1989-02-27 1992-03-24 E. R. Squibb & Sons, Inc. Mevinic acid derivatives useful as antihypercholesterolemic agents and method for preparing same
US5140012A (en) * 1990-05-31 1992-08-18 E. R. Squibb & Sons, Inc. Method for preventing onset of restenosis after angioplasty employing pravastatin
US5202029A (en) * 1991-03-13 1993-04-13 Caron Kabushiki Kaisha Process for purification of hmg-coa reductase inhibitors
US5157025A (en) * 1991-04-01 1992-10-20 E. R. Squibb & Sons, Inc. Method for lowering serum cholesterol employing a phosphorus containing ace inhibitor alone or in combination with a cholesterol lowering drug
NZ250609A (en) * 1992-12-28 1995-07-26 Sankyo Co Hexahydronaphthalene esters and ring closed lactones; preparation and medicaments
SI9300303A (en) 1993-06-08 1994-12-31 Krka Tovarna Zdravil Process for isolation of hypolipemic effective substance
US5942423A (en) 1995-06-07 1999-08-24 Massachusetts Institute Of Technology Conversion of compactin to pravastatin by actinomadura
US5616595A (en) 1995-06-07 1997-04-01 Abbott Laboratories Process for recovering water insoluble compounds from a fermentation broth
US5883109A (en) * 1996-07-24 1999-03-16 Bristol-Myers Squibb Company Method for lowering serum lipid levels employing an MTP inhibitor in combination with another cholesterol lowering drug
US6165757A (en) * 1997-02-20 2000-12-26 Dsm N.V. Nitrogen feed in statin fermentation
EP1015600A1 (en) * 1997-08-22 2000-07-05 Dsm N.V. Statin production by fermentation
SI9800046A (sl) * 1998-02-18 1999-08-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze visoke čistosti
SI20072A (sl) * 1998-09-18 2000-04-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze
HRP20010577B1 (en) * 1999-02-03 2005-12-31 Institute For Drug Research Ltd. Microbial process for preparing pravastatin
US6682913B1 (en) * 1999-02-03 2004-01-27 Institute For Drug Research Ltd. Microbial process for preparing pravastatin
HUP9902352A1 (hu) 1999-07-12 2000-09-28 Gyógyszerkutató Intézet Kft. Eljárás pravasztatin mikrobiológiai előállítására
ES2273737T3 (es) * 1999-11-30 2007-05-16 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Procedimiento para la recuperacion de compuestos de estatina de un caldo de fermentacion.
HRP20030347A2 (en) * 2000-10-05 2005-04-30 Teva Gy�gyszergy�r R�szv�nyt�rsas�g Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and compositions containing same

Also Published As

Publication number Publication date
ATE382344T1 (de) 2008-01-15
US20040115781A1 (en) 2004-06-17
SK7342002A3 (en) 2004-03-02
EP1265604A4 (en) 2004-06-16
JP4343987B2 (ja) 2009-10-14
DE60031447T2 (de) 2007-08-30
JP3881240B2 (ja) 2007-02-14
CA2393057C (en) 2008-01-29
MXPA02005283A (es) 2003-10-06
PT1265604E (pt) 2006-12-29
CN1433305A (zh) 2003-07-30
CN1754872A (zh) 2006-04-05
HUP0204012A3 (en) 2003-12-29
ES2273737T3 (es) 2007-05-16
JP2006273861A (ja) 2006-10-12
DK1265604T3 (da) 2007-02-05
JP2003515334A (ja) 2003-05-07
US6689590B2 (en) 2004-02-10
JP2004350687A (ja) 2004-12-16
HUP0204012A2 (hu) 2003-03-28
AU1804601A (en) 2001-06-12
US20020187531A1 (en) 2002-12-12
PL364918A1 (en) 2004-12-27
JP2008109948A (ja) 2008-05-15
ES2239937T1 (es) 2005-10-16
US6444452B1 (en) 2002-09-03
EP1265604A1 (en) 2002-12-18
DE60037687D1 (de) 2008-02-14
ATE342717T1 (de) 2006-11-15
KR20030026920A (ko) 2003-04-03
ZA200203912B (en) 2003-08-21
JP2006055174A (ja) 2006-03-02
DE04010770T1 (de) 2005-10-20
YU39102A (sh) 2006-01-16
RU2002114072A (ru) 2004-07-20
EP1265604B1 (en) 2006-10-18
CA2393057A1 (en) 2001-06-07
DE60031447D1 (de) 2006-11-30
WO2001039768A1 (en) 2001-06-07
HRP20020454A2 (en) 2005-10-31

Similar Documents

Publication Publication Date Title
CY1105925T1 (el) Διepγασια για ανακτηση ενωσεων στατινης απο ενα ζωμο ζυμωσης
AU5115493A (en) Method of obtaining 10-deacetylbaccatine iii
SE8902264L (sv) 2-(5-fluoronikotinoyl)-aettiksyraderivat och foerfarande foer framstaellning av detta
YU63602A (sh) Postupak za prečišćavanje fermentacionog bujona
ATE153332T1 (de) Verfahren zur herstellung von oxetanonen
CY1106910T1 (el) Διαδικασια για την παρασκευη διυδροξυ εστερων και παραγωγων αυτων
ATE370254T1 (de) Verfahren zur herstellung hochreinen tantals für zerstäubungstargets
PT885191E (pt) Resolucao de treo-metilfenidato
ATE200892T1 (de) Ein verfahren zur herstellung des kondensationsproduktes einer carbonsäure
ES2040248T3 (es) Metodo de preparacion de derivados de inososa.
ATE253037T1 (de) Verfahren zur racematspaltung von tramadol
DK0784605T3 (da) Selektiv fremgangsmåde til deacyleringen af acylforbindelser
EE04593B1 (et) Alendroonhappe valmistamismeetod
ATE283367T1 (de) Verfahren zur gewinnung von bakteriorhodopsin
ES2178158T3 (es) Procedimiento de recuperacion de acido lactico.
DE69710212D1 (de) Verfahren zur gewinnung von ascorbinsäure
ATE245161T1 (de) Verfahren zur synthese von phosphororganischen verbindungen
EA199900282A2 (ru) Способ получения феноксифенилсульфонилгалогенидов
ATE261931T1 (de) Verfahren zur synthese alpha-substituierter ringsysteme
CY1110375T1 (el) Μεθοδος παρασκευης του 4,10 βητα-διακετοξυ-2-αλφα-βενζοϋλοξυ-5 βητα 20-εποξυ-1,13 αλφα-διυδροξυ-9-οξο-19-νορκυκλοπροπα[g]ταξ-11-ενιου
ATE299147T1 (de) Verfahren zur herstellung von 3-amino-1,5- benzodiazepinderivaten
DK0961770T3 (da) Fremgangsmåder til fremstilling af 3-cyanopyridin ud fra 2-methyl-1,5-pentandiamin
DE50001638D1 (de) Verfahren zur herstellung von 4,6-dichlorpyrimidin
Keri et al. Method of purifying statins from a fermentation broth
AU1020101A (en) Method for preparing an organic compound and method for recovering a co-catalyst